KALOSAR
Live / Applied — Fourth extension granted (statement of use) (as of 24 May 2025)
What this means for you
Not registered yet, but its 31 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97436611
- Mark type
- Stylized text
- Filed
- 31 May 2022
- Published for opposition
- 18 Apr 2023
- Attorney of record
- Maxim A. Voltchenko
Goods and services
- Class 005 — Pharmaceuticals: Dermatological pharmaceutical products
Owner
- Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ, US
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, US
Prosecution history
- 08 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 25 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 May 2025 — SOU EXTENSION 4 GRANTED
- 24 May 2025 — SOU EXTENSION 4 FILED
- 24 May 2025 — SOU TEAS EXTENSION RECEIVED
- 19 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Nov 2024 — SOU EXTENSION 3 GRANTED
- 27 Nov 2024 — SOU EXTENSION 3 FILED
- 26 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 May 2024 — SOU EXTENSION 2 GRANTED